Trish Simner
Cited by
Cited by
Understanding the promises and hurdles of metagenomic next-generation sequencing as a diagnostic tool for infectious diseases
PJ Simner, S Miller, KC Carroll
Clinical Infectious Diseases 66 (5), 778-788, 2018
Extended-spectrum β-lactamases: an update on their characteristics, epidemiology and detection
M Castanheira, PJ Simner, PA Bradford
JAC-antimicrobial resistance 3 (3), dlab092, 2021
Comparing the outcomes of patients with carbapenemase-producing and non-carbapenemase-producing carbapenem-resistant Enterobacteriaceae bacteremia
PD Tamma, KE Goodman, AD Harris, T Tekle, A Roberts, A Taiwo, ...
Clinical Infectious Diseases 64 (3), 257-264, 2017
Modified carbapenem inactivation method for phenotypic detection of carbapenemase production among Enterobacteriaceae
VM Pierce, PJ Simner, DR Lonsway, DE Roe-Carpenter, JK Johnson, ...
Journal of clinical microbiology 55 (8), 2321-2333, 2017
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006
GG Zhanel, M DeCorby, N Laing, B Weshnoweski, R Vashisht, F Tailor, ...
Antimicrobial agents and chemotherapy 52 (4), 1430-1437, 2008
Phenotypic detection of carbapenemase-producing organisms from clinical isolates
PD Tamma, PJ Simner
Journal of clinical microbiology 56 (11), 10.1128/jcm. 01140-18, 2018
Can multidrug-resistant Candida auris be reliably identified in clinical microbiology laboratories?
M Mizusawa, H Miller, R Green, R Lee, M Durante, R Perkins, C Hewitt, ...
Journal of clinical microbiology 55 (2), 638-640, 2017
Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008)
GG Zhanel, M DeCorby, H Adam, MR Mulvey, M McCracken, ...
Antimicrobial agents and Chemotherapy 54 (11), 4684-4693, 2010
A primer on AmpC β-lactamases: necessary knowledge for an increasingly multidrug-resistant world
PD Tamma, Y Doi, RA Bonomo, JK Johnson, PJ Simner, ...
Clinical Infectious Diseases 69 (8), 1446-1455, 2019
Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase-and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian …
AJ Denisuik, PRS Lagacé-Wiens, JD Pitout, MR Mulvey, PJ Simner, ...
Journal of Antimicrobial Chemotherapy 68 (suppl_1), i57-i65, 2013
Antimicrobial resistance in urinary tract pathogens in Canada from 2007 to 2009: CANWARD surveillance study
JA Karlowsky, PRS Lagacé-Wiens, PJ Simner, MR DeCorby, HJ Adam, ...
Antimicrobial agents and chemotherapy 55 (7), 3169-3175, 2011
Comparison of a novel, rapid chromogenic biochemical assay, the Carba NP test, with the modified Hodge test for detection of carbapenemase-producing Gram-negative bacilli
S Vasoo, SA Cunningham, PC Kohner, PJ Simner, JN Mandrekar, ...
Journal of clinical microbiology 51 (9), 3097-3101, 2013
Multicenter evaluation of the Accelerate PhenoTest BC kit for rapid identification and phenotypic antimicrobial susceptibility testing using morphokinetic cellular analysis
P Pancholi, KC Carroll, BW Buchan, RC Chan, N Dhiman, B Ford, ...
Journal of clinical microbiology 56 (4), 10.1128/jcm. 01329-17, 2018
Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE)
KE Goodman, PJ Simner, PD Tamma, AM Milstone
Expert review of anti-infective therapy 14 (1), 95-108, 2016
Comparison of 11 phenotypic assays for accurate detection of carbapenemase-producing Enterobacteriaceae
PD Tamma, BNA Opene, A Gluck, KK Chambers, KC Carroll, PJ Simner
Journal of clinical microbiology 55 (4), 1046-1055, 2017
Carbapenem-resistant non-glucose-fermenting gram-negative bacilli: the missing piece to the puzzle
TJ Gniadek, KC Carroll, PJ Simner
Journal of clinical microbiology 54 (7), 1700-1710, 2016
Comparing the analytical performance of three SARS-CoV-2 molecular diagnostic assays
K Uhteg, J Jarrett, M Richards, C Howard, E Morehead, M Geahr, L Gluck, ...
Journal of Clinical Virology 127, 104384, 2020
Metagenomic next-generation sequencing of nasopharyngeal specimens collected from confirmed and suspect COVID-19 patients
HH Mostafa, JA Fissel, B Fanelli, Y Bergman, V Gniazdowski, M Dadlani, ...
MBio 11 (6), 10.1128/mbio. 01969-20, 2020
Activity of NXL104 in combination with β-lactams against genetically characterized Escherichia coli and Klebsiella pneumoniae isolates producing class A extended-spectrum β …
PRS Lagacé-Wiens, F Tailor, P Simner, M DeCorby, JA Karlowsky, ...
Antimicrobial agents and chemotherapy 55 (5), 2434-2437, 2011
Cefiderocol antimicrobial susceptibility testing considerations: the Achilles' heel of the Trojan horse?
PJ Simner, R Patel
Journal of clinical microbiology 59 (1), 10.1128/jcm. 00951-20, 2020
The system can't perform the operation now. Try again later.
Articles 1–20